Metastatic Cancer Disease clinical trials

Explore recruiting metastatic cancer disease clinical trials.

Recruiting metastatic cancer disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Cancer Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PARASTOP – Paracetamol with Strong Opioids. A randomized, double-blind, parallel-group non-inferiority phase III withdrawal trial of paracetamol versus placebo in conjunction with opioids for moderate to severe cancer-related pain

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metastatic Cancer Disease trials by city

Metastatic Cancer Disease clinical trials

Recruiting metastatic cancer disease studies right now

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

18F-FLUC PET/MR in Patients With Brain Mets

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

Personalized NK Cell Therapy in CBT

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases

Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases

Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread

Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)

TheraSphere Japan Pre-Market Study

BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer

A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Also recruiting in Europe

PARASTOP – Paracetamol with Strong Opioids. A randomized, double-blind, parallel-group non-inferiority phase III withdrawal trial of paracetamol versus placebo in conjunction with opioids for moderate to severe cancer-related pain

Metastatic Cancer Disease trials by city

Other conditions